Related Experiment Video
Updated: May 26, 2026
06:27
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
Central role for interleukin-2 in type 1 diabetes
Maigan A Hulme1, Clive H Wasserfall, Mark A Atkinson
1Department of Pathology, University of Florida, Gainesville, Florida, USA.
Diabetes
|December 22, 2011
Summary
Deficiencies in interleukin-2 (IL-2) signaling contribute to type 1 diabetes pathogenesis. Restoring IL-2 signaling may prevent and reverse type 1 diabetes by enhancing regulatory T-cell function.
Area of Science:
- Immunology
- Endocrinology
- Molecular Biology
Background:
- Type 1 diabetes involves immune-mediated pancreatic beta-cell destruction leading to hyperglycemia.
- Genetic and immunological studies link type 1 diabetes to defects in the interleukin-2 (IL-2) receptor and its signaling pathway.
Purpose of the Study:
- To explore the molecular framework of deficient IL-2 signaling in type 1 diabetes pathogenesis.
- To identify novel therapeutic targets for restoring immune regulation in type 1 diabetes.
Main Methods:
- Review of genetic and immunological studies on IL-2 signaling in type 1 diabetes.
- Analysis of animal models demonstrating the effects of augmenting IL-2 signaling.
Main Results:
- Deficient IL-2 signaling is a central defect in type 1 diabetes.
- Augmenting IL-2 signaling in animal models prevents and reverses disease progression.
- Restoration of regulatory T-cell (Treg) function is key to IL-2 mediated protection.
Conclusions:
- Deficient IL-2 signaling is a critical factor in type 1 diabetes development.
- Targeting the IL-2 pathway offers potential therapeutic strategies for type 1 diabetes.
- Restoring immune regulation via IL-2 augmentation is a promising approach for type 1 diabetes treatment.
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...